February 2012 Editor's Picks: Products from ACS Valves and G-Con Manufacturing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

February 2012 Editor's Picks: Products from ACS Valves and G-Con Manufacturing

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

ACS Valves
Rotary feeder introduces powders to pneumatic conveying systems

ACS Valves’s Aero-Flow series of rotary feeders is designed for pneumatic conveying of dense materials such as fine powders. The feeders use a proprietary, dual-induction endplate design that introduces pressurized air from both endplates into the rotor pockets carrying process material. The high bulk density material, when mixed with air, is more effectively released from the rotor pockets and is more efficiently introduced to the pneumatically conveyed material flow.

While single-induction designs have only one source of pressure-conveying air, the second air source in the dual-induction functionality is intended to improve aeration and flowability of products with sticky material characteristics. The feeder is designed to integrate with most pharmaceutical pneumatic conveying applications, and the dual-induction design’s applications are appropriate for applications in which the material’s characteristics make efficient material transfer challenging. The feeder is available with 304 and 316 stainless-steel cast housing for sanitary applications.


Sartorius Stedim Biotech and G-Con Manufacturing
Global collaboration offers integrated production process platforms

Sartorius Stedim Biotech (SSB) and G-Con have agreed to a global collaboration to offer advanced and flexible production platforms for biopharmaceutical manufacturing. The new product line will create an integrated production process platform by combining G-Con Manufacturing’s modular, mobile cleanroom “pods” and SSB’s single-use and reusable product portfolio. SSB has incorporated its products into unit operations for media/buffer preparation, seed fermentation, cell cultivation and harvesting, ultra-diafiltration, membrane chromatography, and viral clearance for biopharmaceutical development and manufacturing.

Maik Jornitz, SSB’s Senior Vice President of Marketing for Bioprocess Solutions, stated in a Jan. 18, 2012, release, “Our vision is to create standardized unit operations, implemented into the self-contained G-Con modules. These modules can be used as individual process units or joined to an entire process. The combined product portfolio will fundamentally change the way biopharmaceutical manufacturing processes will be designed and configured.”

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Equipment and Processing Report,
Click here